(Q34589793)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17160910%20AND%20SRC:MED&resulttype=core&format=json

22 December 2019

review article

1 reference

title

Dipeptidyl peptidase IV (DPP IV) inhibitors: A newly emerging drug class for the treatment of type 2 diabetes (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17160910%20AND%20SRC:MED&resulttype=core&format=json

22 December 2019

1 reference

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17160910%20AND%20SRC:MED&resulttype=core&format=json

22 December 2019

Clifford J Bailey

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17160910%20AND%20SRC:MED&resulttype=core&format=json

22 December 2019

author name string

Brian D Green

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17160910%20AND%20SRC:MED&resulttype=core&format=json

22 December 2019

language of work or name

English

0 references

publication date

1 December 2006

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17160910%20AND%20SRC:MED&resulttype=core&format=json

Diabetes and Vascular Disease Research

22 December 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17160910%20AND%20SRC:MED&resulttype=core&format=json

22 December 2019

volume

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17160910%20AND%20SRC:MED&resulttype=core&format=json

22 December 2019

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17160910%20AND%20SRC:MED&resulttype=core&format=json

22 December 2019

page(s)

159-165

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17160910%20AND%20SRC:MED&resulttype=core&format=json

Dipeptidyl-peptidase IV (CD26)--role in the inactivation of regulatory peptides

22 December 2019

cites work

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2006.024

CD26: a multifunctional integral membrane and secreted protein of activated lymphocytes.

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2006.024

Inhibition of dipeptidylpeptidase IV activity as a therapy of type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2006.024

Structurally modified analogues of glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP) as future antidiabetic agents

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2006.024

Antibiotic treatment for uncomplicated neuropathic forefoot ulcers in diabetes: a controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2006.024

Glucagon-like peptide-1: from extract to agent. The Claude Bernard Lecture, 2005.

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2006.024

Inhibitors of dipeptidyl peptidase IV: a novel approach for the prevention and treatment of Type 2 diabetes?

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2006.024

Therapeutic potential of dipeptidyl peptidase IV inhibitors for the treatment of type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2006.024

Minireview: Glucagon-like peptides regulate cell proliferation and apoptosis in the pancreas, gut, and central nervous system

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2006.024

Reduced hepatic insulin extraction in response to gastric inhibitory polypeptide compensates for reduced insulin secretion in normal-weight and normal glucose tolerant first-degree relatives of type 2 diabetic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2006.024

Glucagon-like peptide 1: a potent glycogenic hormone

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2006.024

Inositolphosphoglycans are possible mediators of the glucagon-like peptide 1 (7-36)amide action in the liver

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2006.024

Glucose-dependent insulinotropic polypeptide stimulation of lipolysis in differentiated 3T3-L1 cells: wortmannin-sensitive inhibition by insulin.

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2006.024

Inhibition of gastric inhibitory polypeptide signaling prevents obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2006.024

Glucagon-like peptide-1(7-36) amide (GLP-1) enhances insulin-stimulated glucose metabolism in 3T3-L1 adipocytes: one of several potential extrapancreatic sites of GLP-1 action.

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2006.024

The glucagon-like peptide-1 metabolite GLP-1-(9-36) amide reduces postprandial glycemia independently of gastric emptying and insulin secretion in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2006.024

Structural and kinetic analysis of the substrate specificity of human fibroblast activation protein alpha

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2006.024

Dipeptidyl peptidase IV and related enzymes in cell biology and liver disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2006.024

Kinetic investigation of human dipeptidyl peptidase II (DPPII)-mediated hydrolysis of dipeptide derivatives and its identification as quiescent cell proline dipeptidase (QPP)/dipeptidyl peptidase 7 (DPP7).

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2006.024

Enhanced insulin secretion and improved glucose tolerance in mice lacking CD26.

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2006.024

Improved glucose tolerance via enhanced glucose-dependent insulin secretion in dipeptidyl peptidase IV-deficient Fischer rats

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2006.024

Improvement of high fat-diet-induced insulin resistance in dipeptidyl peptidase IV-deficient Fischer rats

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2006.024

Mice lacking dipeptidyl peptidase IV are protected against obesity and insulin resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2006.024

Dipeptidyl peptidase IV inhibition reduces the degradation and clearance of GIP and potentiates its insulinotropic and antihyperglycemic effects in anesthetized pigs

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2006.024

Improved glucose tolerance in Zucker fatty rats by oral administration of the dipeptidyl peptidase IV inhibitor isoleucine thiazolidide

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2006.024

Long-term treatment with the dipeptidyl peptidase IV inhibitor P32/98 causes sustained improvements in glucose tolerance, insulin sensitivity, hyperinsulinemia, and beta-cell glucose responsiveness in VDF (fa/fa) Zucker rats

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2006.024

Dipeptidyl peptidase IV inhibitor treatment stimulates beta-cell survival and islet neogenesis in streptozotocin-induced diabetic rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2006.024

Long-term inhibition of dipeptidyl peptidase IV improves glucose tolerance and preserves islet function in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2006.024

Chronic inhibition of dipeptidyl peptidase-4 with a sitagliptin analog preserves pancreatic beta-cell mass and function in a rodent model of type 2 diabetes.

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2006.024

Acute and chronic effects of the incretin enhancer vildagliptin in insulin-resistant rats

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2006.024

Enteroinsular axis of db/db mice and efficacy of dipeptidyl peptidase IV inhibition

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2006.024

Applications of dipeptidyl peptidase IV inhibitors in diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2006.024

Inhibition of dipeptidyl peptidase IV improves metabolic control over a 4-week study period in type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2006.024

Inhibition of dipeptidyl peptidase-4 reduces glycemia, sustains insulin levels, and reduces glucagon levels in type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2006.024

Improved glycaemic control with dipeptidyl peptidase-4 inhibition in patients with type 2 diabetes: vildagliptin (LAF237) dose response

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2006.024

Vildagliptin, a dipeptidyl peptidase-IV inhibitor, improves model-assessed beta-cell function in patients with type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2006.024

Vildagliptin therapy reduces postprandial intestinal triglyceride-rich lipoprotein particles in patients with type 2 diabetes.

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2006.024

Twelve- and 52-week efficacy of the dipeptidyl peptidase IV inhibitor LAF237 in metformin-treated patients with type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2006.024

Improved meal-related beta-cell function and insulin sensitivity by the dipeptidyl peptidase-IV inhibitor vildagliptin in metformin-treated patients with type 2 diabetes over 1 year

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2006.024

Evaluation of the effect of gain on the meal response of an automated closed-loop insulin delivery system

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2006.024

Association of systemic chemokine concentrations with impaired glucose tolerance and type 2 diabetes: results from the Cooperative Health Research in the Region of Augsburg Survey S4 (KORA S4).

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2006.024

Incretin secretion in relation to meal size and body weight in healthy subjects and people with type 1 and type 2 diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2006.024

Hematopoietic stimulation by a dipeptidyl peptidase inhibitor reveals a novel regulatory mechanism and therapeutic treatment for blood cell deficiencies

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2006.024

Dipeptidyl peptidase IV inhibition for the treatment of type 2 diabetes: potential importance of selectivity over dipeptidyl peptidases 8 and 9.

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2006.024

Effect of metformin on glucagon-like peptide 1 (GLP-1) and leptin levels in obese nondiabetic subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2006.024

Reduced serum dipeptidyl peptidase-IV after metformin and pioglitazone treatments

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2006.024

Inhibition of dipeptidyl peptidase IV activity by oral metformin in Type 2 diabetes.

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2006.024

Metformin effects on dipeptidylpeptidase IV degradation of glucagon-like peptide-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2006.024

Enhanced secretion of glucagon-like peptide 1 by biguanide compounds

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2006.024

Endoproteolysis of glucagon-like peptide (GLP)-1 (7-36) amide by ectopeptidases in RINm5F cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2006.024

Neutral endopeptidase 24.11 and dipeptidyl peptidase IV are both mediators of the degradation of glucagon-like peptide 1 in the anaesthetised pig.

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2006.024

Inhibition of dipeptidyl peptidase IV with NVP-DPP728 increases plasma GLP-1 (7-36 amide) concentrations and improves oral glucose tolerance in obese Zucker rats

21 January 2018

1 reference

https://api.crossref.org/works/10.3132%2FDVDR.2006.024

21 January 2018

Identifiers

DOI

10.3132/DVDR.2006.024

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17160910%20AND%20SRC:MED&resulttype=core&format=json

22 December 2019

1 reference